If its Hepalink once again ponying up the cash, then the lower the PPS the more shares they get for their money obviously...at $6 they would have gotten half as many from the most recent offering.  

Resverlogix maintains a weak cash position, just enough to last another month or so... which to my way of thinking helps keep the risk profile nicely elevated, and Hepalink profits imo by getting millions more shares cheap.